Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

LOGIN TO START A DISCUSSION
Filter by Research and Meeting News
Research and Meeting News
William F. Pirl, MD
Sep 25, 2013 11:31 AM
Cancer centers will have to meet the American College of Surgeons Commission on Cancer new standard of screening programs for psychosocial distress by 2015 for accreditation. The Screening for Psychosocial Distress Program (...
Research and Meeting News
Megan Webster
Feb 04, 2013 11:02 AM
The American Association for the Study of Liver Diseases invites you to join us for the Emerging Trends Conference: Reactivation of Hepatitis B, March 21-22 in Arlington, VA. ASCO member, Robin T. Zon, MD is speaking as part of a panel discussion at this conference. Learn more:...
Research and Meeting News
ASCO Admin
Dec 03, 2012 10:43 AM
Following the 2012 Quality Care Symposium, ASCO presents its latest video on CancerLinQ™
Research and Meeting News
Nagwa Abdel Rahman Ibrahim, PharmD, PhD
Nov 27, 2012 11:54 AM
Even though it is almost five months since the 2012 ASCO Annual Meeting, I felt it would be nice to share my experience with my colleagues to encourage those planning to attend next year. I planned to attend the ASCO meeting few years back but unfortunately was not able to make it. Glad I managed...
Research and Meeting News
Daily News
Sep 14, 2012 1:52 PM
Cornelia Liedtke, MD, PhD Cornelia Liedtke, MD, PhD Triple-negative breast cancer (TNBC) is defined by a lack of expression of the estrogen (ER) and progesterone (PR) receptors, as well as by a lack of overexpression/ amplification of the oncogene HER2/ neu.1 Therefore,...

Pages